Lafond Kevin G 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 12, 2021
Insider Transaction Report
Form 4
Lafond Kevin G
Vice Pres., Treasurer, & CAO
Transactions
- Sale
Common Stock
2021-01-08$3.09/sh−18,020$55,682→ 63,965 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to satisfy withholding tax obligations upon the vesting of restricted stock grants.